Administrative Supplements to Cancer Centers Support Grants to Stimulate Collaborative HIV Malignancy Research in Low and Middle Income Countries
The purpose of this initiative is to stimulate HIV malignancy research via support of collaborative pilot projects in NCI-designated Cancer Centers (CC) and low and middle income countries (LMICs), per World Bank classification. Findings from this collaboration could potentially improve cancer control, prevention and treatment strategies in the US and the LMIC. The supplements are intended to:
- Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
Partners: University of California San Francisco and Infectious Diseases Institute in Uganda. The consortium will focus on the two most common cancers in Uganda, Kaposi’s sarcoma (KS) and cervical cancer. The consortium will build capacity for research on HIV-associated cancers in Uganda through mentoring, pilot projects and K-like awards and explore strategies for increasing community and provider awareness and diagnosis of KS and cervical cancers.